A paper in Medical Gas Research argues that carbon dioxide — sensed as a host-environment signal by fungi — is a master regulator of virulence and drug response in medically relevant species. Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans, and other human-pathogenic fungi modulate their gene expression, hyphal growth, biofilm formation, and stress response in response to CO2 concentrations in different host niches.
The authors describe how the fungal carbonic anhydrase / cAMP-PKA axis links environmental CO2 to virulence-program activation, and they catalog the evidence that elevated CO2 also alters susceptibility to several classes of antifungal drugs. They propose that CO2-aware in vitro testing may improve the predictive value of antifungal susceptibility assays.
The paper is framed as a perspective on host-environment sensing and does not propose new clinical interventions, but it highlights a sensing pathway that links environmental conditions to human fungal disease.